Test Overview
Clinical Utility
Disopyramide is useful in treating patients with cardiac arrhythmias and tachcardia. Therapeutic drug monitoring is useful to optimize dose and avoid toxicity.
Method
Immunoassay (IA)
Result Included
Disopyramide
Aliases/Synonyms
Norpace®
Specimen
Specimen Type
Avoid gel separator tubesSerum
Plasma (Heparin)
Plasma (EDTA)
Containers
Preferred Containers
Serum (red top)
Acceptable Containers
Plasma sodium heparin green top; Plasma EDTA lavender top
Volume
Sample Volume
1 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Centrifuge and immediately separate serum or plasma specimens from the cells.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 5 days | 14 days | 35 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Specimen | Gel-separator |
Performance & Interpretation
Turnaround Time
7 days
Results
Name
Units
Reference Range
Conversion
-
Disopyramidemg/L2.0 - 5.0
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| DISOP | DISOPYRAMIDE | 62201 | mg/L |
Test Version
Last Updated
2019-11-20